Literature DB >> 29992471

The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells.

Igor I Slukvin1,2,3, Akhilesh Kumar4.   

Abstract

Mesenchymoangioblast (MB) is the earliest precursor for endothelial and mesenchymal cells originating from APLNR+PDGFRα+KDR+ mesoderm in human pluripotent stem cell cultures. MBs are identified based on their capacity to form FGF2-dependent compact spheroid colonies in a serum-free semisolid medium. MBs colonies are composed of PDGFRβ+CD271+EMCN+DLK1+CD73- primitive mesenchymal cells which are generated through endothelial/angioblastic intermediates (cores) formed during first 3-4 days of clonogenic cultures. MB-derived primitive mesenchymal cells have potential to differentiate into mesenchymal stromal/stem cells (MSCs), pericytes, and smooth muscle cells. In this review, we summarize the specification and developmental potential of MBs, emphasize features that distinguish MBs from other mesenchymal progenitors described in the literature and discuss the value of these findings for identifying molecular pathways leading to MSC and vasculogenic cell specification, and developing cellular therapies using MB-derived progeny.

Entities:  

Keywords:  Cardiovascular progenitors; Embryonic mesenchyme; Embryonic stem cells; Hemangioblasts; Human pluripotent stem cells; Induced pluripotent stem cells; Mesenchymal stem cells; Mesenchymoangioblasts; Mesoangioblast; Mesoderm development; Mesospheres; Pericytes; Smooth muscles

Mesh:

Year:  2018        PMID: 29992471      PMCID: PMC6328351          DOI: 10.1007/s00018-018-2871-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  101 in total

1.  Cell populations and morphogenetic movements underlying formation of the avian primitive streak and organizer.

Authors:  A Lawson; G C Schoenwolf
Journal:  Genesis       Date:  2001-04       Impact factor: 2.487

2.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.

Authors:  Linzhao Cheng; Nancy F Hansen; Ling Zhao; Yutao Du; Chunlin Zou; Frank X Donovan; Bin-Kuan Chou; Guangyu Zhou; Shijie Li; Sarah N Dowey; Zhaohui Ye; Settara C Chandrasekharappa; Huanming Yang; James C Mullikin; P Paul Liu
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

3.  Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene.

Authors:  I Dekel; Y Magal; S Pearson-White; C P Emerson; M Shani
Journal:  New Biol       Date:  1992-03

4.  Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.

Authors:  Pavithra S Iyer; Lionel O Mavoungou; Flavio Ronzoni; Joanna Zemla; Emanuel Schmid-Siegert; Stefania Antonini; Laurence A Neff; Olivier M Dorchies; Marisa Jaconi; Malgorzata Lekka; Graziella Messina; Nicolas Mermod
Journal:  Mol Ther       Date:  2018-02-02       Impact factor: 11.454

5.  Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis.

Authors:  E Devic; L Paquereau; P Vernier; B Knibiehler; Y Audigier
Journal:  Mech Dev       Date:  1996-10       Impact factor: 1.882

6.  Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.

Authors:  Francesco Saverio Tedesco; Mattia F M Gerli; Laura Perani; Sara Benedetti; Federica Ungaro; Marco Cassano; Stefania Antonini; Enrico Tagliafico; Valentina Artusi; Emanuela Longa; Rossana Tonlorenzi; Martina Ragazzi; Giorgia Calderazzi; Hidetoshi Hoshiya; Ornella Cappellari; Marina Mora; Benedikt Schoser; Peter Schneiderat; Mitsuo Oshimura; Roberto Bottinelli; Maurilio Sampaolesi; Yvan Torrente; Vania Broccoli; Giulio Cossu
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

7.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

8.  piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

Authors:  Mariana Loperfido; Susan Jarmin; Sumitava Dastidar; Mario Di Matteo; Ilaria Perini; Marc Moore; Nisha Nair; Ermira Samara-Kuko; Takis Athanasopoulos; Francesco Saverio Tedesco; George Dickson; Maurilio Sampaolesi; Thierry VandenDriessche; Marinee K Chuah
Journal:  Nucleic Acids Res       Date:  2015-12-17       Impact factor: 16.971

Review 9.  Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.

Authors:  Marcin Majka; Maciej Sułkowski; Bogna Badyra; Piotr Musiałek
Journal:  Stem Cells Transl Med       Date:  2017-08-24       Impact factor: 6.940

10.  Aging of mesenchymal stem cell in vitro.

Authors:  Mandana Mohyeddin Bonab; Kamran Alimoghaddam; Fatemeh Talebian; Syed Hamid Ghaffari; Ardeshir Ghavamzadeh; Behrouz Nikbin
Journal:  BMC Cell Biol       Date:  2006-03-10       Impact factor: 4.241

View more
  14 in total

Review 1.  Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells.

Authors:  Bruno Moisés de Matos; Anny Waloski Robert; Marco Augusto Stimamiglio; Alejandro Correa
Journal:  Stem Cell Rev Rep       Date:  2021-09-20       Impact factor: 5.739

Review 2.  Stem Cell-Based Therapies: What Interventional Radiologists Need to Know.

Authors:  Hyeon Yu; Clayton W Commander; Joseph M Stavas
Journal:  Semin Intervent Radiol       Date:  2021-11-24       Impact factor: 1.780

3.  Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.

Authors:  Adrian J C Bloor; Amit Patel; James E Griffin; Maria H Gilleece; Rohini Radia; David T Yeung; Diana Drier; Laurie S Larson; Gene I Uenishi; Derek Hei; Kilian Kelly; Igor Slukvin; John E J Rasko
Journal:  Nat Med       Date:  2020-09-14       Impact factor: 53.440

4.  The MSC-MCF-7 Duet Playing Tumor Vasculogenesis and Angiogenesis onto the Chick Embryo Chorioallantoic Membrane.

Authors:  Şerban ComŞa; Amalia-Raluca CeauȘu; Roxana Popescu; Simona SÂrb; Anca-Maria CÎmpean; Marius Raica
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 5.  Understanding the Journey of Human Hematopoietic Stem Cell Development.

Authors:  Akhilesh Kumar; Saritha S D'Souza; Abir S Thakur
Journal:  Stem Cells Int       Date:  2019-05-06       Impact factor: 5.443

Review 6.  Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions.

Authors:  Antonio Filippini; Alessio D'Alessio
Journal:  Biomolecules       Date:  2020-08-21

Review 7.  Stem Cell-Based Clinical Trials for Diabetes Mellitus.

Authors:  Eleonora de Klerk; Matthias Hebrok
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-26       Impact factor: 6.055

Review 8.  Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology.

Authors:  Naoki Nakayama; Sudheer Ravuri; Johnny Huard
Journal:  Bioengineering (Basel)       Date:  2021-04-10

Review 9.  Eph/ephrin Signaling and Biology of Mesenchymal Stromal/Stem Cells.

Authors:  David Alfaro; Mariano R Rodríguez-Sosa; Agustín G Zapata
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

Review 10.  Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis.

Authors:  Pablo Scharf; Milena Fronza Broering; Gustavo Henrique Oliveira da Rocha; Sandra Helena Poliselli Farsky
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.